Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non–small cell lung cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|121|23|4165-4172

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.23, 2015-12, pp. : 4165-4172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Erlotinib in Patients with Previously Irradiated, Recurrent Brain Metastases from Non-Small Cell Lung Cancer: Two Case Reports

By  

Oncology Research and Treatment, Vol. 31, Iss. 3, 2008-02 ,pp. : 123-126

Karger

Access to resources Recommend Favorite

Whole Brain Radiotherapy-Based Combined Modality Treatment of Brain Metastases from Non-Small Cell Lung Cancer: A Retrospective Analysis of Prognostic Factors

By  

Oncology Research and Treatment, Vol. 38, Iss. 1-2, 2015-01 ,pp. : 35-40

Karger

Access to resources Recommend Favorite

Reply to comparative effectiveness of stereotactic radiosurgery versus whole‐brain radiation therapy for patients with brain metastases from breast or non–small cell lung cancer

By  

CANCER, Vol. 122, Iss. 20, 2016-10 ,pp. : 3244-3245

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparative effectiveness of stereotactic radiosurgery versus whole‐brain radiation therapy for patients with brain metastases from breast or non–small cell lung cancer

By  

CANCER, Vol. 122, Iss. 20, 2016-10 ,pp. : 3243-3244

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combination Chemotherapy of Cisplatin, Ifosfamide, and Irinotecan with rhG-CSF Support in Patients with Brain Metastases from Non-Small Cell Lung Cancer

By  

Oncology, Vol. 59, Iss. 4, 2000-11 ,pp. : 291-295

Karger

Access to resources Recommend Favorite